Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it will webcast its corporate presentation at the Goldman Sachs 29th Annual Global Healthcare Conference on Wednesday, June 11, 2008 at 4:00 p.m. PDT (7:00 p.m. EDT).
The presentation will be webcast live and may be accessed from Â˜Events & PresentationsÂ™ on the home page of VertexÂ™s website at www.vrtx.com. A replay of the webcast will also be available on the CompanyÂ™s website for two weeks following the presentation. To ensure a timely connection, it is recommended that users register at least 15 minutes prior to the scheduled webcast.
Vertex Pharmaceuticals Incorporated is a global biotechnology company committed to the discovery and development of breakthrough small molecule drugs for serious diseases. The CompanyÂ™s strategy is to commercialize its products both independently and in collaboration with major pharmaceutical companies. VertexÂ™s product pipeline is focused on viral diseases, inflammation, autoimmune diseases, cancer, pain and cystic fibrosis. Vertex co-discovered the HIV protease inhibitor, Lexiva, with GlaxoSmithKline.
Lexiva is a registered trademark of the GlaxoSmithKline group of companies.
VertexÂ™s press releases are available at www.vrtx.com.
Vertex Pharmaceuticals Incorporated
Lora Pike, 617-444-6755
Manager, Investor Relations